| Current Medical Articles |
|---|
 |
Lucire
January 17, 2016 |
To your good health Alex Barrow flies to Malaysia to examine first-hand the phenomenon of medical tourism, and why the country is fast becoming the destination of choice   |
Chemistry World
January 11, 2016
Phillip Broadwith |
GSK's ViiV to buy HIV drugs from BMS Bristol-Myers Squibb has agreed to sell its entire portfolio of investigational HIV drugs as the company seeks to exit research in virology. |
Fast Company
Christina Farr |
Bill Gates, Illumina To Fund $100M Blood Test For Cancer Bill Gates, Jeff Bezos's venture fund Bezos Expeditions, and Arch Venture Partners will also contribute to the venture. Grail will be based in San Francisco, and Illumina will retain majority control. |
Chemistry World
January 6, 2016
Rebecca Trager |
US bans microbeads from personal care products The new law, which is aimed at protecting the nation's waterways, will also ban sales of cosmetics containing microbeads beginning July 2018, and over-the-counter drugs containing these plastic particles by July 2019. |
Fast Company
Christina Farr |
KaloBios Files for Bankruptcy After Former CEO Martin Shkreli's Arrest The bad news keeps on coming for business associates of Martin Shkreli, the "bad boy" of pharmaceuticals who made a name for himself earlier this year. |
Chemistry World
December 24, 2015
Jennifer Newton |
AstraZeneca to buy Acerta for blood cancer drug AstraZeneca has agreed to buy a majority stake in Acerta Pharma, a privately-owned biopharmaceutical company based in the Netherlands and US. |
Chemistry World
December 23, 2015
Chris Chapman |
Big pharma At its core, the game is an elaborate jigsaw puzzle, asking you to weave production lines between different apparatus. The aim is to hit the sweet spot in the concentration range, producing a drug that works with minimal side effects. |
Chemistry World
December 22, 2015
Mark Archibald |
FDA finally approves anesthetic antidote Merck & Co have gained approval from the US Food and Drug Administration at the fourth attempt for their anesthesia-reversing drug Bridion (sugammadex). |
Chemistry World
December 21, 2015
Jennifer Newton |
Mexico approves world's first dengue vaccine Dengvaxia from Sanofi's vaccines division, Sanofi Pasteur, protects against all four dengue virus serotypes and will be aimed at residents in endemic areas aged nine to 45. |
Chemistry World
December 21, 2015
Katrina Kramer |
BioAtla and Pfizer to collaborate on antibody research BioAtla and Pfizer will share expertise to develop tumor-targeting antibodies chemically bound to cytotoxic drugs. |
Chemistry World
December 21, 2015
Phillip Broadwith |
Is bigger really better? Something that's often glossed over in the aftermath of a pharmaceutical mega-merger is whether savings actually materialize, and at what cost to the future success of the businesses. |
Fast Company
Christina Farr |
Bayer Partners With Gene-Editing Startup CRISPR To Develop New Drugs Bayer, the European pharmaceutical giant, is establishing a partnership with a gene-editing startup, CRISPR Therapeutics, and investing at least $300 million over a five-year period. |
Fast Company
Christina Farr |
Five Moments Leading Up To Arrest of Pharma's "Bad Boy" Martin Shkreli has stepped down from his post as CEO of Turing Pharmaceuticals, just one day after federal authorities charged the "bad boy" of biotech with securities fraud. |
Chemistry World
December 17, 2015
Sarah Houlton |
Pills, prices and politics Pharmaceutical pricing has been a hot topic in 2015, with the drugs bill continuing to rise as costly new treatments reach the market. |
CRM
December 4, 2015 |
Veeva Systems Releases Medical CRM Veeva Medical CRM is designed to help improve key opinion leader engagement. |
Information Today
December 10, 2015 |
NLM Rolls Out Health Literacy Instrument Resource Researchers can use it to select a health literacy research instrument and learn background information, as well as compare various instruments. |
Chemistry World
December 9, 2015
Philippa Matthews |
Heptares makes new partners for drug discovery UK drug discovery and development company Heptares has entered a string of drug discovery collaborations with major pharmaceutical firms, potentially worth over $1 billion. |
Chemistry World
December 8, 2015
Colacci & Kleinstreuer |
Rethinking risk assessment For the purposes of regulation, the onset of adverse effects is key to determining the level of exposure that presents an unreasonable risk for humans and ecosystems. |
Chemistry World
December 8, 2015
Jennifer Newton |
Pfizer to close Cambridge pain outpost Pfizer plans to shut down its Neusentis site on the outskirts of Cambridge, UK, in a move that will eliminate up to 120 jobs. |
Chemistry World
December 8, 2015
Phillip Broadwith |
Perrigo nabs US rights to AZ Crohn's drug Irish drug maker Perrigo has fended off a hostile takeover bid from rival Mylan, and agreed to buy the US distribution rights to AstraZeneca's gastroenterology drug Entocort (budesonide). |
Fast Company
Sean Captain |
Google Life Sciences Rebrands As Verily, Uses Big Data To Figure Out Why We Get Sick Verily marks Google's/Alphabet's formal entry into the burgeoning field of companies intent on gaining health insights using sensors, digital medical records, AI, and more. |
Chemistry World
December 7, 2015
Andy Extance |
Pfizer's response to compound fraud spotlights quality issues After a bogus version of its leukemia drug bosutinib was supplied to researchers, Pfizer scientists have laid out how they check they have produced the right compound. |
Commercial Investment Real Estate
Nov/Dec 2015
Sara Drummond |
Medical Office Miracle Big and small MOB investments are up adding to a record year. |
| There are 9197 old articles available for this category. |
